Physician profile
Emily Boss
NPI 1265924088
$1,011.21
in general payments reported to CMS, 2019-2025
7 companies · $75.48 in 2025
The $75.48 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $17.68 · 2021: $79.88 · 2022: $119 · 2023: $236 · 2024: $483 · 2025: $75.48.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $725 · Entertainment: $69.60.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $724.56 |
| Entertainment | $69.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $380.25 | 2020-2025 | Acuvue |
| Alcon Vision LLC | $258.69 | 2021-2025 | Precision 1, Dailies Total1, Dailies |
| Coopervision INC. | $255.26 | 2021-2025 | Myday Contact Lens, Clariti Contact Lens |
| Optos, INC. | $69.60 | 2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Biotissue Holdings INC. | $21.14 | 2024 | |
| Oyster Point Pharma, INC. | $13.47 | 2024 | Ryzumvi, Tyrvaya |
| Allergan, INC. | $12.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Boss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.